# Altimmune, Inc.: Form 8-K, filed Oct 27, 2026

- Company: [Altimmune, Inc.](/companies/alt.md) (CIK 1326190)
- Form: 8-K
- Filed: 2026-10-27
- Accepted by EDGAR: Oct 27, 2026, 08:16 ET
- Period: 2026-10-23
- Accession: 0001104659-26-118991
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326190/000110465926118991/tm2628339d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326190/000110465926118991/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326190/000110465926118991/tm2628339d1_8k.htm

Filed Oct 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-118991. Last ingested by Listed: Nov 14, 2026, 20:51 ET. No prices; not investment advice.
